Pharmacovigilance Market Analysis 2023-2032: Market Size, Trends, Forecast Analysis | IQVIA, Cognizant, ICON Plc, PAREXEL International Corporation

Year End Offer By The Business Research Company - Get 33% Discount On Opportunities And Strategies Reports And 25% Discount On Global Market Reports

The Business Research Company's latest "Global Pharmacovigilance Opportunities And Strategies Market Report - Forecast To 2032" is the most comprehensive report available in market that will help gain a truly global perspective with data and statistics from over 60 geographies analyzed with more than 7500 market segments. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth and highlights important trends and strategies that can be adopted to beat the competition in the industry

Download FREE SAMPLE Report - https://www.thebusinessresearchcompany.com/sample_request?id=12807&type=smp

The global pharmacovigilance market reached a value of nearly $6,715.5 million in 2022, having increased at a compound annual growth rate (CAGR) of 8.5% since 2017. The market is expected to grow from $6,715.5 million in 2022 to $12,569.8 million in 2027 at a rate of 13.4%. The market is then expected to grow at a CAGR of 12.3% from 2027 and reach $22,416.8 million in 2032.

The pharmacovigilance market consists of sales of pharmacovigilance services by entities (organizations, sole traders, and partnerships) that collect, assess, and distribute drug safety and efficacy data.

Companies in the pharmacovigilance market are focusing on innovative cloud-based systems to strengthen their position in the market. Cloud-based systems can help the pharmaceutical industry become more efficient, cost-effective, and innovative. By utilizing cloud computing, pharma companies can streamline their processes, improve data management, and accelerate drug discovery, ultimately leading to better patient outcomes. For example, in February 2019, ICON plc, an Ireland-based company that provides drug development solutions and services to the pharmaceutical, biotechnology and medical device industries released a new drug safety reporting solution based on an innovative cloud-based system, featuring automated and configurable business rules. The technology guarantees compliance in an increasingly complex regulatory environment and gives the sponsor visibility into the investigational product's safety profile over the course of its lifecycle. The system has additional reporting capabilities and a dashboard that displays submissions individually and collectively at the study and portfolio levels. This gives the sponsor more transparency to oversee and monitor drug safety.

Pharmacovigilance Market Segmentation:

By Type -
The pharmacovigilance market is segmented by type into
a) Spontaneous Reporting
b) Intensified ADR Reporting
c) Targeted Spontaneous Reporting
d) Cohort Event Monitoring
e) EHR Mining

By Service Provider -
The pharmacovigilance market is also segmented by service provider into
a) In-House
b) Contract Outsourcing

By End-User -
The pharmacovigilance market is also segmented by end-user into
a) Hospitals
b) Pharmaceutical Companies
c) Other End Users

By Clinical Trial Phases -
The pharmacovigilance market is also segmented by clinical trial phases into
a) Preclinical
b) Phase I
c) Phase II
d) Phase III
e) Phase IV

By Process Flow -
The pharmacovigilance market is also segmented by process flow into
a) Case Data Management
b) Signal Detection
c) Risk Management System

By Geography -
North America was the largest region in the pharmacovigilance market.

Some of the key players involved in the Pharmacovigilance market are IQVIA, Cognizant, ICON Plc., Accentur*e plc, PAREXEL International Corporation.

The regions covered in the global Pharmacovigilance market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Complete Report @
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-market

A Few Points From The Table Of Content
1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
……………………………………..
19. Competitive Landscape and Company Profiles
20. Key Mergers And Acquisitions
21. Opportunities And Strategies
22. Pharmacovigilance Market, Conclusions And Recommendations
23. Appendix

Place a DIRECT PURCHASE ORDER of the report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12807

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.